In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-Epigenetic Modulation

Current genome-editing systems generally rely on the creation of DNA double-strand breaks (DSBs). This may limit their utility in clinical therapies, as unwanted mutations caused by DSBs can have deleterious effects. The CRISPR/Cas9 system has recently been repurposed to enable target gene activatio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell
Autores principales: Liao, Hsin-Kai, Hatanaka, Fumiyuki, Araoka, Toshikazu, Reddy, Pradeep, Wu, Min-Zu, Sui, Yinghui, Yamauchi, Takayoshi, Sakurai, Masahiro, O'Keefe, David, Nuñez, Estrella, Guillen, Pedro, Campistol, Josep M., Wu, Cheng-Jang, Lu, Li-Fan, Esteban, Concepcion Rodriguez, Izpisua Belmonte, Juan Carlos
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732045/
https://ncbi.nlm.nih.gov/pubmed/29224783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2017.10.025
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares